Plasma proteomics at the crossroads: Technological innovations driving clinical translation
Journal of Pharmaceutical and Biomedical Analysis · 2027-02 · 284 · 117798
DOI: 10.1016/j.jpba.2026.117798 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical and Biomedical Analysis, 2027-02. Verfasst von Ying Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Component-Based Chinese Medicine, Tianjin Key Laboratory of TCM Chemistry and Analysis, Haihe Laboratory of Modern Chinese Me…. Die Arbeit nennt 166 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Component-Based Chinese Medicine, Tianjin Key Laboratory of TCM Chemistry and Analysis, Haihe Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, 10 Poyangh…
Zitieren
APA
Wang, Y., He, N., Ocholi, S. S., Chen, Q., Liu, E., Xu, X., & Han, L. (2027). Plasma proteomics at the crossroads: Technological innovations driving clinical translation. Journal of Pharmaceutical and Biomedical Analysis, 284, 117798. https://doi.org/10.1016/j.jpba.2026.117798
Vancouver
Wang Y, He N, Ocholi SS, Chen Q, Liu E, Xu X, et al. Plasma proteomics at the crossroads: Technological innovations driving clinical translation. Journal of Pharmaceutical and Biomedical Analysis. 2027;284:117798. doi:10.1016/j.jpba.2026.117798
BibTeX
@article{Wang2027,
author = {Wang, Ying and He, Nuoyun and Ocholi, Simon Sani and Chen, Qiqi and Liu, Erwei and Xu, Xia and Han, Lifeng},
title = {Plasma proteomics at the crossroads: Technological innovations driving clinical translation},
journal = {Journal of Pharmaceutical and Biomedical Analysis},
year = {2027},
volume = {284},
pages = {117798},
doi = {10.1016/j.jpba.2026.117798}
}
EUVIMED